PBH FY 2020 Earnings Report — Prestige Consumer Healthcare Inc. Revenue & Financial Results | Market Cap Arena

Prestige Consumer Healthcare Inc.PBH

FY 2020 Earnings

Reported May 8, 2020

Quarter Comparison

Revenue

Operating Income

Gross Margin

Net Margin

EPS (Diluted)

Free Cash Flow

Metric	FY 2020	Prior Q	FY 2019	QoQ Change	YoY Change
Revenue	$963M	—	$976M	—	-1.3%
Op. Income	$291M	—	$68M	—	331.3%
Gross Margin	57.3%	—	56.9%	—	0.4pp
Net Margin	14.8%	—	-3.7%	—	18.4pp
EPS (Diluted)	$2.78	—	$-0.69	—	502.9%
Free Cash Flow	$203M	—	$179M	—	13.3%

Revenue Flow

Item	Amount
REVENUE	$963M
Cost of Revenue	$411M
GROSS PROFIT	$552M
R&D Expenses	$0
Selling & Marketing	$147M
General & Administrative	$89M
SG&A Expenses	$236M
Other Expenses	$25M
Operating Expenses	$261M
Cost & Expenses	$672M
OPERATING INCOME	$291M
Interest Income	$342.0K
Interest Expense	$97M
Other Income/Expenses	-$100M
INCOME BEFORE TAX	$191M
Income Tax Expense	$49M
Net Income from Continuing Ops	$142M
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$142M
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$142M
D&A	$38M
EBIT	$288M
EBITDA	$325M
EPS	$3
EPS Diluted	$3

Income Statement

Item	Amount
REVENUE	$963M
Cost of Revenue	$411M
GROSS PROFIT	$552M
R&D Expenses	$0
Selling & Marketing	$147M
General & Administrative	$89M
SG&A Expenses	$236M
Other Expenses	$25M
Operating Expenses	$261M
Cost & Expenses	$672M
OPERATING INCOME	$291M
Interest Income	$342.0K
Interest Expense	$97M
Other Income/Expenses	-$100M
INCOME BEFORE TAX	$191M
Income Tax Expense	$49M
Net Income from Continuing Ops	$142M
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$142M
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$142M
D&A	$38M
EBIT	$288M
EBITDA	$325M
EPS	$3
EPS Diluted	$3

Cash Flow Statement

Item	Amount
Net Income	$142M
Depreciation & Amortization	$29M
Stock-Based Compensation	$8M
Deferred Income Tax	$14M
Other Non-Cash Items	$16M
Change in Working Capital	$9M
OPERATING CASH FLOW	$217M
Capital Expenditure	-$15M
Acquisitions (Net)	-$3M
Purchases of Investments	$0
Sales/Maturities of Investments	$0
Other Investing Activities	$750.0K
NET CASH FROM INVESTING	-$17M
Net Debt Issuance	-$68M
Common Stock Repurchased	-$57M
Common Dividends Paid	$0
Other Financing Activities	-$6M
NET CASH FROM FINANCING	-$131M
FREE CASH FLOW	$203M
Net Change in Cash	$67M

Balance Sheet

Item	Amount
Cash & Equivalents	$95M
Short-Term Investments	$0
Net Receivables	$151M
Inventory	$116M
Other Current Assets	$0
TOTAL CURRENT ASSETS	$366M
PP&E (Net)	$91M
Goodwill	$575M
Intangible Assets	$2.5B
Long-Term Investments	$0
Tax Assets	$0
Other Non-Current Assets	$3M
TOTAL NON-CURRENT ASSETS	$3.1B
TOTAL ASSETS	$3.5B
Account Payables	$62M
Short-Term Debt	$0
Deferred Revenue	$0
Other Current Liabilities	$13M
TOTAL CURRENT LIABILITIES	$150M
Long-Term Debt	$1.7B
Deferred Revenue NC	$0
Deferred Tax Liabilities	$408M
Other Non-Current Liabilities	$25M
TOTAL NON-CURRENT LIABILITIES	$2.2B
TOTAL LIABILITIES	$2.3B
Common Stock	$538.0K
Additional Paid-In Capital	$488M
Retained Earnings	$844M
Treasury Stock	-$118M
Accum. Other Comp. Income	-$44M
Other Equity	$0
TOTAL STOCKHOLDERS' EQUITY	$1.2B
Minority Interest	$0
TOTAL EQUITY	$1.2B
TOTAL LIABILITIES & EQUITY	$3.5B
Total Debt	$1.8B
Net Debt	$1.7B